Plazomicin for infections caused by carbapenem-resistant Enterobacteriaceae

New England Journal of Medicine

Volumn 380, Issue 8, 2019, Pages 791-793

  McKinnell, James A ^a   Dwyer, Jamie P ^b   Talbot, George H ^c   Connolly, Lynn E ^d   Friedland, Ian ^d   Smith, Alex ^d   Jubb, Adrian M ^d   Serio, Alisa W ^d   Krause, Kevin M ^d   Daikos, George L ^e  

^a LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Talbot   (United States)

^d Achaogen   (United States)

^e UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; CREATININE; MEROPENEM; PLAZOMICIN; TIGECYCLINE; 6'-(HYDROXYLETHYL)-1-(HABA)-SISOMICIN; ANTIINFECTIVE AGENT; SISOMICIN;

BLOODSTREAM INFECTION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE INFECTION; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; ENTEROBACTERIACEAE INFECTION; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; LETTER; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA; ANALOGS AND DERIVATIVES; ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL PNEUMONIA; BLOOD; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; CLINICAL TRIAL; COMPLICATION; INTENTION TO TREAT ANALYSIS; KAPLAN MEIER METHOD; MORTALITY; SAMPLE SIZE;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; COLISTIN; CREATININE; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; HEALTHCARE-ASSOCIATED PNEUMONIA; HUMANS; INTENTION TO TREAT ANALYSIS; KAPLAN-MEIER ESTIMATE; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; SAMPLE SIZE; SISOMICIN;

EID: 85061989923     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1807634     Document Type: Letter

References (5)

1. World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed. February 27, 2017 (http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/).
2. Hauck C, Cober E, Richter SS, et al. Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections. Clin Microbiol Infect 2016;22:513-9.
3. Guidance for industry: antibacterial therapies for patients with an unmet medical need for the treatment of serious bacterial diseases. Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research, 2013.
4. Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 2009;20:672-9.
5. Wagenlehner FME, Cloutier DJ, Komirenko AS, et al. Once-daily plazomicin for complicated urinary tract infections. N Engl J Med 2019;380:729-40.